.avif)
Sunovion Pharmaceuticals Email Format
Pharmaceutical Manufacturing
・
1,001-2,500 employees
・
Marlborough, MA, USA
Sunovion Pharmaceuticals is a pharmaceutical company that develops and commercializes therapies for central nervous system disorders, respiratory diseases, and oncology in the United States and globally.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
first.last@sunovion.com
Company Overview
Industry
Pharmaceutical Manufacturing
Founded
2010
Headquarters
Marlborough, MA, USA
Revenue
$250M-$500M
FUNDING Stage
Subsidiary
Website
Key Executives
Tsutomu Nakagawa (President and Chief Executive Officer), Ron Gimbel (Chief Financial Officer), Andrew Hetherington (Chief Technology & Quality Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Sunovion Pharmaceuticals?
Sunovion Pharmaceuticals uses the first.last format, so Jane Smith would be jane.smith@sunovion.com.
What therapeutic areas does Sunovion Pharmaceuticals focus on?
Sunovion Pharmaceuticals focuses primarily on central nervous system disorders and respiratory conditions, with key products including Latuda for schizophrenia and bipolar I depression, Lunesta for insomnia, and Lonhala Magnair for COPD.
Which flagship Sunovion Pharmaceuticals product treats both schizophrenia and bipolar I depression?
Latuda (lurasidone HCl) is the flagship Sunovion Pharmaceuticals product indicated for schizophrenia in adults and adolescents as well as for major depressive episodes associated with bipolar I disorder.
How can I find a verified contact at Sunovion Pharmaceuticals for outreach?
Because Sunovion Pharmaceuticals uses the first.last@sunovion.com format, you can build and verify contact addresses directly in Clay by combining a person's first and last name with that domain pattern.
When did Sunovion Pharmaceuticals become part of Sumitomo Pharma America?
Sunovion Pharmaceuticals became the surviving legal entity when Sumitomo Pharma merged seven of its U.S. subsidiaries into a single company in July 2023, forming Sumitomo Pharma America, and is headquartered in Marlborough, Massachusetts.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating